Ran Cheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ran Cheng has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Hui Yang
State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, China
2 shared publications- Li Cheng
State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Frontier Innovation Center for Dental Medicine Plus, West China Hospital of Stomatology, Sichuan University, Chengdu, China
2 shared publications - Tao Hu
State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Frontier Innovation Center for Dental Medicine Plus, West China Hospital of Stomatology, Sichuan University, Chengdu, China
2 shared publications Feng-Ming Wang
1 shared publicationH. Y. Pan
State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China
1 shared publicationH. Yang
State Key Laboratory of Oral Diseases West China Hospital of Stomatology Sichuan University Chengdu China
1 shared publication
Latest Publications
- 16 June 2014
- Published by Wiley in International Endodontic Journal
- Vol. 48 (5) , 460-468
Sphingosine‐1‐phosphate mediates AKT/ERK maintenance of dental pulp homoeostasis
Aim: To investigate the cell status of dental pulp cells (DPCs) in a sphingosine‐1‐phosphate (S1P)‐induced microinflammation environment and the possible mechanisms of cell homoeostasis maintenance by S1P.Methodology: Sphingosine‐1‐phosphate receptor (S1PR) expression was examined in DPCs within a local S1P‐induced microinflammation model established using 1 μmol L−1 S1P. U0126 [extracellular signal‐regulated kinase (ERK) inhibitor], LY294002 (AKT inhibitor) and Y27632 (ROCK inhibitor) were used to inhibit corresponding signalling pathways of DPCs. CCK8 and cell cycle analysis tested cell proliferation. Immunofluorescence staining JC‐1 detected changes of mitochondrial membrane potential (ΔΨm). Tests for apoptosis and the apoptosis‐related proteins Bax and Bcl‐2 were assessed by flow cytometry and western blot analysis, respectively. Expressions of ERK and AKT were evaluated by western blot analysis. The results were analysed using the Student's t‐test and the significance level set at P < 0.05.Results: Expressions of S1PR1, S1PR2 and S1PR3 in DPCs differed amongst individuals. DPCs maintained self‐homoeostasis in response to S1P‐induced microinflammation via S1PRs. During this repair process, ERK, AKT and ROCK had a short‐term complementary interaction at 60 min, but then AKT and ERK gradually played decisive roles after 24 h in proliferation enhancement and apoptosis inhibition, respectively (P > 0.05).Conclusions: The AKT–ERK balance may determine whether DPC homoeostasis in S1P‐induced microinflammation is maintained by synergistic regulation of cell growth and apoptosis.
- 16 June 2014
- Published by Wiley in International Endodontic Journal
- Vol. 48 (5) , 460-468
Sphingosine‐1‐phosphate mediates AKT/ERK maintenance of dental pulp homoeostasis
Aim: To investigate the cell status of dental pulp cells (DPCs) in a sphingosine‐1‐phosphate (S1P)‐induced microinflammation environment and the possible mechanisms of cell homoeostasis maintenance by S1P.Methodology: Sphingosine‐1‐phosphate receptor (S1PR) expression was examined in DPCs within a local S1P‐induced microinflammation model established using 1 μmol L−1 S1P. U0126 [extracellular signal‐regulated kinase (ERK) inhibitor], LY294002 (AKT inhibitor) and Y27632 (ROCK inhibitor) were used to inhibit corresponding signalling pathways of DPCs. CCK8 and cell cycle analysis tested cell proliferation. Immunofluorescence staining JC‐1 detected changes of mitochondrial membrane potential (ΔΨm). Tests for apoptosis and the apoptosis‐related proteins Bax and Bcl‐2 were assessed by flow cytometry and western blot analysis, respectively. Expressions of ERK and AKT were evaluated by western blot analysis. The results were analysed using the Student's t‐test and the significance level set at P < 0.05.Results: Expressions of S1PR1, S1PR2 and S1PR3 in DPCs differed amongst individuals. DPCs maintained self‐homoeostasis in response to S1P‐induced microinflammation via S1PRs. During this repair process, ERK, AKT and ROCK had a short‐term complementary interaction at 60 min, but then AKT and ERK gradually played decisive roles after 24 h in proliferation enhancement and apoptosis inhibition, respectively (P > 0.05).Conclusions: The AKT–ERK balance may determine whether DPC homoeostasis in S1P‐induced microinflammation is maintained by synergistic regulation of cell growth and apoptosis.
- 1 February 2014
- Published by Elsevier in Journal of Endodontics
- Vol. 40 (2) , 217-222
Lysophosphatidic Acid Rescues Human Dental Pulp Cells from Ischemia-induced Apoptosis
- 1 February 2014
- Published by Elsevier in Journal of Endodontics
- Vol. 40 (2) , 217-222
Lysophosphatidic Acid Rescues Human Dental Pulp Cells from Ischemia-induced Apoptosis
- 1 April 2010
- Published by Elsevier in Experimental Cell Research
- Vol. 316 (6) , 1019-1027
Roles of lysophosphatidic acid and the Rho-associated kinase pathway in the migration of dental pulp cells
- 1 April 2010
- Published by Elsevier in Experimental Cell Research
- Vol. 316 (6) , 1019-1027
Roles of lysophosphatidic acid and the Rho-associated kinase pathway in the migration of dental pulp cells